Form 4: Merit Medical Systems Director Michael McDonnell Receives Stock Grant

Director Michael McDonnell received 2,431 restricted stock units from Merit Medical Systems, vesting in May 2025.

Summary

• Michael R. McDonnell, a director of Merit Medical Systems Inc., received 2,431 restricted stock units (RSUs) on May 16, 2024.
• The RSUs were granted under the company's 2018 Long-Term Incentive Plan.
• These RSUs will vest on May 16, 2025, contingent upon McDonnell's continued service to the company.
• Following the transaction, McDonnell directly owns 7,743 shares of Merit Medical Systems Inc. common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard executive compensation practice, indicating confidence in the director's continued service and the company's future.

Positives

• The grant of RSUs aligns the director's interests with the long-term performance of the company.
• The vesting requirement encourages continued service and commitment from the director.

Risks

• The value of the RSUs is subject to the performance of Merit Medical Systems Inc.'s stock price.
• If McDonnell ceases to be a director before May 16, 2025, the RSUs will not vest.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting of the RSUs in May 2025.

Industry Context

Stock grants are a common form of executive compensation in the medical device industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Stock grants are a typical component of compensation packages for directors in publicly traded companies, including those in the medical device sector.
• Companies like Medtronic, Stryker, and Boston Scientific also utilize stock grants and options as part of their executive compensation plans to incentivize performance and retain key personnel.
• The size of the grant is relative to the size of the company and the director's role.

Stakeholder Impact

• Shareholders may view the stock grant positively as it aligns the director's interests with the company's long-term success.
• Employees may see this as a sign of stability and commitment from the company's leadership.

Key Dates